Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender

Psychological Medicine

Volumn 42, Issue 9, 2012, Pages 1903-1911

  Dekker, N ^a   Meijer, J ^a   Koeter, M ^a,b   Van Den Brink, W ^a,b   Van Beveren, N ^c   Kahn, R S ^d   Linszen, D H ^a   Van Os, J ^e   Wiersma, D ^f   Bruggeman, R ^f   Cahn, W ^d   De Haan, L ^a   Krabbendam, L ^e   Myin Germeys, I ^e  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b AMSTERDAM INSTITUTE FOR ADDICTION RESEARCH   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cannabis; gender; illness onset; psychosis; schizophrenia; substance use

Indexed keywords

ADDICTION; ADULT; ARTICLE; CANNABIS SMOKING; COHORT ANALYSIS; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; ONSET AGE; PSYCHOSIS; REGRESSION ANALYSIS; SCHIZOPHRENIA; SEX DIFFERENCE;

ADULT; AGE OF ONSET; COHORT STUDIES; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; PRECIPITATING FACTORS; PSYCHOTIC DISORDERS; REGRESSION ANALYSIS; SCHIZOPHRENIA; SEX FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 84864536688     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291712000062     Document Type: Article

References (44)

1. Addington J, Addington D (2007). Patterns, predictors and impact of substance use in early psychosis : A longitudinal study. Acta Psychiatrica Scandinavica 115, 304-309.
2. Aleman A, Kahn RS, Selten JP (2003). Sex differences in the risk of schizophrenia : Evidence from meta-analysis. Archives of General Psychiatry 60, 565-571.
3. Andreasen NC, Flaum M, Arndt S (1992). The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry 49, 615-623.
4. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association : Washington, DC.
5. Barnes TR, Mutsatsa SH, Hutton SB, Watt HC, Joyce EM (2006). Comorbid substance use and age at onset of schizophrenia. British Journal of Psychiatry 188, 237-242.
6. Barnett JH, Werners U, Secher SM, Hill KE, Brazil R, Masson K, Pernet DE, Kirkbride JB, Murray GK, Bullmore ET, Jones PB (2007). Substance use in a population-based clinic sample of people with first-episode psychosis. British Journal of Psychiatry 190, 515-520.
7. Barrigon ML, Gurpegui M, Ruiz-Veguilla M, Diaz FJ, Anguita M, Sarramea F, Cervilla J (2010). Temporal relationship of first-episode non-affective psychosis with cannabis use : A clinical verification of an epidemiological hypothesis. Journal of Psychiatric Research 44, 413-420.
8. Bersani G, Orlandi V, Kotzalidis GD, Pancheri P (2002). Cannabis and schizophrenia : Impact on onset, course, psychopathology and outcomes. European Archives of Psychiatry and Clinical Neuroscience 252, 86-92.
9. Brady KT, Lydiard RB, Malcolm R, Ballenger JC (1991). Cocaine-induced psychosis. Journal of Clinical Psychiatry 52, 509-512.
10. Buhler B, Hambrecht M, Loffler W, an der Heiden W, Hafner H (2002). Precipitation and determination of the onset and course of schizophrenia by substance abuse-a retrospective and prospective study of 232 population-based first illness episodes. Schizophrenia Research 54, 243-251.
11. Castle D, Sham P, Murray R (1998). Differences in distribution of ages of onset in males and females with schizophrenia. Schizophrenia Research 33, 179-183.
12. De Hert M, Wampers M, Jendricko T, Franic T, Vidovic D, De Vriendt N, Sweers K, Peuskens J, van Winkel R (2011). Effects of cannabis use on age at onset in schizophrenia and bipolar disorder. Schizophrenia Research 126, 270-276.
13. Dekker N, de Haan L, Berg S, Gier M, Becker H, Linzen DH (2008). Cessation of cannabis use by patients with recent-onset schizophrenia and related disorders. Psychopharmacology Bulletin 41, 142-153.
14. Dekker N, Smeerdijk AM, Wiers RW, Duits JH, van Gelder G, Houben K, Schippers G, Linszen DH, de Haan L (2010). Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls. Psychological Medicine 40, 1325-1336.
15. DeRosse P, Kaplan A, Burdick KE, Lencz T, Malhotra AK (2010). Cannabis use disorders in schizophrenia : Effects on cognition and symptoms. Schizophrenia Research 120, 95-100.
16. Divisie Psychiatrie Academisch Ziekenhuis Utrecht (2003). Dutch Version of the Comprehensive Assessment of Symptoms and History (CASH). Divisie Psychiatrie Academisch Ziekenhuis Utrecht : Utrecht.
17. Dragt S, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, de Haan L, van Amelsvoort TA, Linszen DH (2010). Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis. Canadian Journal of Psychiatry 55, 165-171.
18. Estrada G, Fatjó-Vilas M, Munoz MJ, Pulido G, Minano MJ, Toledo E, Illa JM, Mart?́n M, Miralles ML, Miret S, Campanera S, Bernabeu C, Navarro ME, Fananás L (2011). Cannabis use and age at onset of psychosis : Further evidence of interaction with COMT Val158Met polymorphism. Acta Psychiatrica Scandinavica 123, 485-492.
19. Foti DJ, Kotov R, Guey LT, Bromet EJ (2010). Cannabis use and the course of schizophrenia : 10-year follow-up after first hospitalization. American Journal of Psychiatry 167, 987-993.
20. Giel R, Nienhuis FJ (2001). SCAN 2.1 : Dutch Version of the Schedules for Clinical Assessment in Neuropsychiatry. Harcourt Test Publishers : Amsterdam.
21. Goldberger C, Dervaux A, Gourion D, Bourdel MC, Loo H, Laqueille X, Krebs MO (2010). Variable individual sensitivity to cannabis in patients with schizophrenia. International Journal of Neuropsychopharmacology 13, 1145-1154.
22. Gonza'lez-Pinto A, Vega P, Ibánez B, Mosquera F, Barbeito S, Gutiérrez M, Ruiz de Azú a S, Ruiz I, Vieta E (2008). Impact of cannabis and other drugs on age at onset of psychosis. Journal of Clinical Psychiatry 69, 1210-1216.
23. Hafner H (2003). Gender differences in schizophrenia. Psychoneuroendocrinology 28 (Suppl. 2), 17-54.
24. Hambrecht M, Häfner H (1996). Substance abuse and the onset of schizophrenia. Biological Psychiatry 40, 1155-1163.
25. Hambrecht M, Maurer K, Häfner H, Sartorius N (1992). Translational stability of gender differences in schizophrenia? An analysis based on the WHO study on determinants of outcome of severe mental disorders. European Archives of Psychiatry and Clinical Neuroscience 242, 6-12.
26. Korver N, Quee PJ, Boos H, Simons CJP, Genetic Risk and Outcome of Psychosis (GROUP) Investigators (in press). Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene-environment interaction : Objectives, sample characteristics, recruitment and assessment methods. International Journal of Methods in Psychiatric Research.
27. Landabaso MA, Iraurgi I, Jimenez-Lerma JM, Calle R, Sanz J, Gutierrez-Fraile M (2002). Ecstasy-induced psychotic disorder : Six-month follow-up study. European Addiction Research 8, 133-140.
28. Large M, Sharma S, Compton MT, Slade T, Nielssen O (2011). Cannabis use and earlier onset of psychosis : A systematic meta-analysis. Archives of General Psychiatry 68, 555-561.
29. Lauronen E, Miettunen J, Veijola J, Karhu M, Jones PB, Isohanni M (2007). Outcome and its predictors in schizophrenia within the Northern Finland 1966 Birth Cohort. European Psychiatry 22, 129-136.
30. Leung A, Chue P (2000). Sex differences in schizophrenia, a review of the literature. Acta Psychiatrica Scandinavica. Supplementum 401, 3-38.
31. Linszen DH, Dingemans PM, Lenior ME (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry 51, 273-279.
32. Mauri MC, Volonteri LS, De Gaspri I, Colasanti A, Brambilla MA, Cerruti L (2006). Substance abuse in first-episode schizophrenic patients : A retrospective study. Clinical Practice and Epidemiology in Mental Health 2, 4.
33. McKetin R, McLaren J, Lubman DI, Hides L (2006). The prevalence of psychotic symptoms among methamphetamine users. Addiction 101, 1473-1478.
34. Ongur D, Lin L, Cohen BM (2009). Clinical characteristics influencing age at onset in psychotic disorders. Comprehensive Psychiatry 50, 13-19.
35. Pelayo-Tera'n JM, Pérez-Iglesias R, Mata I, Carrasco-Marin E, Vazquez-Barquero JL, Crespo-Facorro B (2010). Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis : Clinical-onset implications. Psychiatry Research 179, 291-296.
36. Rabinowitz J, Levine SZ, Hafner H (2006). A population based elaboration of the role of age of onset on the course of schizophrenia. Schizophrenia Research 88, 96-101.
37. Satel SL, Southwick SM, Gawin FH (1990). Clinical features of cocaine induced paranoia. National Institute on Drug Abuse Research Monograph 105, 371.
38. Sevy S, Robinson DG, Napolitano B, Patel RC, Gunduz-Bruce H, Miller R, McCormack J, Lorell BS, Kane J (2010). Are cannabis use disorders associated with an earlier age at onset of psychosis ? A study in first episode schizophrenia. Schizophrenia Research 120, 101-107.
39. Sugranyes G, Flamarique I, Parellada E, Baeza I, Goti J, Fernandez-Egea E, Bernardo M (2009). Cannabis use and age of diagnosis of schizophrenia. European Psychiatry 24, 282-286.
40. Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S, Chakos M, Koreen A, Jody D, Kane J (1995). Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. American Journal of Psychiatry 152, 698-703.
41. Vardy MM, Kay SR (1983). LSD psychosis or LSD-induced schizophrenia ? A multimethod inquiry. Archives of General Psychiatry 40, 877-883.
42. Veen ND, Selten JP, van der Tweel I, Feller WG, Hoek HW, Kahn RS (2004). Cannabis use and age at onset of schizophrenia. American Journal of Psychiatry 161, 501-506.
43. WHO (1994). Composite International Diagnostic Interview : Researchers' Manual. World Health Organization : Geneva.
44. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, Jablenski A, Regier D, Sartorius N (1990). SCAN. Schedules for Clinical Assessment in Neuropsychiatry. American Journal of Psychiatry 47, 589-593.